Halozyme
HALO
414 hedge funds and large institutions have $5.03B invested in Halozyme in 2024 Q1 according to their latest regulatory filings, with 57 funds opening new positions, 163 increasing their positions, 141 reducing their positions, and 51 closing their positions.
243% more call options, than puts
Call options by funds: $20.4M | Put options by funds: $5.96M
100% more funds holding in top 10
Funds holding in top 10: 2 → 4 (+2)
16% more repeat investments, than reductions
Existing positions increased: 163 | Existing positions reduced: 141
12% more first-time investments, than exits
New positions opened: 57 | Existing positions closed: 51
8% more capital invested
Capital invested by funds: $4.66B → $5.03B (+$370M)
2.02% more ownership
Funds ownership: 95.36% → 97.39% (+2%)
1% more funds holding
Funds holding: 410 → 414 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
+$41.3M |
| 2 |
Handelsbanken Fonder
Stockholm,
Sweden
|
+$21.8M |
| 3 |
TD Asset Management
Toronto,
Ontario, Canada
|
+$20.9M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$19.1M |
| 5 |
SCM
Snyder Capital Management
San Francisco,
California
|
+$15.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Artisan Partners
Milwaukee,
Wisconsin
|
-$109M |
| 2 |
Morgan Stanley
New York
|
-$45.2M |
| 3 |
Goldman Sachs
New York
|
-$27M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$21.4M |
| 5 |
BlackRock
New York
|
-$14.6M |
HALO Hedge Fund Activity: Q1 2024 in Review
414 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Halozyme (HALO) for Q1 2024, worth a combined $5.03B — up 7.9% from $4.66B a quarter earlier.
Buyers outnumbered sellers: 57 funds opened new HALO positions and 51 closed out — a net gain of 6 holders — while 163 added to existing stakes and 141 trimmed.
The largest buyer was First Trust Advisors, adding an estimated $41.3M. The largest seller was Artisan Partners, cutting an estimated $109M.
- 414 institutional investors held Halozyme (HALO) as of Q1 2024, up from 410 in Q4 2023.
- Funds reported $5.03B of Halozyme stock for Q1 2024, up 7.9% quarter-over-quarter.
- 57 funds opened new Halozyme positions in Q1 2024 and 51 closed out, a net change of +6 holders.
- The largest Halozyme buyer in Q1 2024 was First Trust Advisors, an estimated $41.3M added.
- The largest Halozyme seller in Q1 2024 was Artisan Partners, an estimated $109M sold.
Based on aggregated 13F filings for Q1 2024.